PAPER Dong MX, Hu L, Wei YD, Chen GH

Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.

Neurosci Lett. 2021 Feb 6;745:135626. Epub 2021 Jan 10 PubMed: 33440238

PAPER Halliday G

Neglected cytotoxic T cell invasion of the brain: how specific for Parkinson's disease?

Brain. 2020 Dec 1;143(12):3518-3521. PubMed: 33439981

PAPER Wilson EL, Metzakopian E

Correction: ER-mitochondria contact sites in neurodegeneration: genetic screening approaches to investigate novel disease mechanisms.

Cell Death Differ. 2021 Jan 12; PubMed: 33437039

PAPER Muthusamy S, Garg P, Chandra RV, Seneviratne U

How common are seizures in the heidenhain variant of creutzfeldt-jakob disease? A case report and systematic review.

J Clin Neurosci. 2021 Jan 9; PubMed: 33436304

PAPER Kletetschka G, Bazala R, Takáč M, Svecova E

Magnetic domains oscillation in the brain with neurodegenerative disease.

Sci Rep. 2021 Jan 12;11(1):714. PubMed: 33436793

PAPER Langmyhr M, Henriksen SP, Cappelletti C, van de Berg WD, Pihlstrøm L, Toft M

Allele-specific expression of Parkinson's disease susceptibility genes in human brain.

Sci Rep. 2021 Jan 12;11(1):504. PubMed: 33436766

PAPER Picillo M, Scannapieco S, Iavarone A, Ginevrino M, Valente EM, Barone P

Posterior Cortical Atrophy phenotype in a GBA N370S mutation carrier: a case report.

BMC Neurol. 2021 Jan 12;21(1):17. PubMed: 33435912

PAPER Spagnolli G, Massignan T, Astolfi A, Biggi S, Rigoli M, Brunelli P, Libergoli M, Ianeselli A, Orioli S, Boldrini A, Terruzzi L, Bonaldo V, Maietta G, Lorenzo NL, Fernandez LC, Codeseira YB, Tosatto L, Linsenmeier L, Vignoli B, Petris G, Gasparotto D, Pennuto M, Guella G, Canossa M, Altmeppen HC, Lolli G, Biressi S, Pastor MM, Requena JR, Mancini I, Barreca ML, Faccioli P, Biasini E

Pharmacological inactivation of the prion protein by targeting a folding intermediate.

Commun Biol. 2021 Jan 12;4(1):62. PubMed: 33437023

PAPER Ibanez A, Schulte M

Situated minds: conceptual and emotional blending in neurodegeneration and beyond.

Brain. 2020 Dec 1;143(12):3523-3525. PubMed: 33439982

PAPER Innok W, Hiranrat A, Chana N, Rungrotmongkol T, Kongsune P

In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.

J Comput Aided Mol Des. 2021 Jan 13; PubMed: 33439402

PAPER Wu J, Shao C, Ye X, Di X, Li D, Zhao H, Zhang B, Chen G, Liu HK, Qian Y

InVivo Brain Imaging of Amyloid-β Aggregates in Alzheimer's Disease with a Near-Infrared Fluorescent Probe.

ACS Sens. 2021 Jan 13; PubMed: 33438997

PAPER Raghavan SS, Iqbal S, Niraikulam A, Gunasekaran K

Insights in the structural understanding of amyloidogenicity and mutation-led conformational dynamics of amyloid beta (Aβ) through molecular dynamics simulations and principal component analysis.

J Biomol Struct Dyn. 2021 Jan 13;:1-11. PubMed: 33438527

PAPER

Erratum to: Alzheimer's disease brain-derived extracellular vesicles spread tau pathology in interneurons.

Brain. 2021 Jan 12; PubMed: 33437996

PAPER Carbone E, Gardini S, Pastore M, Piras F, Vincenzi M, Borella E

Cognitive Stimulation Therapy (CST) for older adults with mild-to-moderate dementia in Italy: effects on cognitive functioning and on emotional and neuropsychiatric symptoms.

J Gerontol B Psychol Sci Soc Sci. 2021 Jan 13; PubMed: 33437991

PAPER Calsolaro V, Bottari M, Coppini G, Lemmi B, Monzani F

Endocrine dysfunction and cognitive impairment.

Minerva Endocrinol. 2021 Jan 12; PubMed: 33435644